Jeff Baxter
Chief Executive Officer at VBI VACCINES INC.
Net worth: 13 381 $ as of 2024-06-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Fried | M | 64 | 9 years | |
| Steven Rubin | M | 63 | 12 years | |
| Steven Gillis | M | 71 |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014.
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 19 years |
| Athena Kartsaklis | F | 59 | 7 years | |
| Nell Beattie | F | 36 | 9 years | |
| Michel de Wilde | M | 74 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | 10 years |
| Scott Requadt | M | 56 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 4 years |
| Francisco Diaz-Mitoma | M | 69 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 17 years |
| Nicole Anderson | F | - | 7 years | |
| Misha Nossov | M | - | 14 years | |
| Joanne Cordeiro | F | 66 | 5 years | |
| Wing Tak Yu | F | 48 | 7 years | |
| Gary Ng | M | 52 | 3 years | |
| Blaine McKee | M | 59 | 5 years | |
| Vaughn Himes | M | 63 | 1 years | |
| David Anderson | M | 54 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | 9 years |
| Damian Braga | M | 68 | 4 years | |
| Andrew Shao | M | - | 4 years | |
| Avi Mazaltov | M | 62 | 7 years | |
| T. Buckley | M | 48 | 23 years | |
| John Dillman | M | 56 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas C. Varvaro | M | 54 | 13 years | |
| Moncef Slaoui | M | 64 | 11 years | |
| Mark Germain | M | 75 | 16 years | |
| Kevin Farr | M | 66 | - | |
| Stephen R. Allen | M | - | 4 years | |
| Troy Allen Rhonemus | M | 51 | 5 years | |
| Alex Worsham | M | - | 5 years | |
| Crispin Davis | M | 75 | 10 years | |
| Tom de Swaan | M | 78 | 9 years | |
| Alex Howarth | M | 55 | 10 years | |
| Megan Jordan | F | - | - | |
| Adam Logal | M | 46 | 3 years | |
| Glenn Halpryn | M | 63 | 5 years | |
| Michèle Barzach | M | - | 7 years | |
| Reid Dabney | M | 72 | 9 years | |
| Daniel Podolsky | M | 70 | 10 years | |
| Hugh Dunkerley | M | 50 | 14 years | |
| Linda Bain | F | 53 | 1 years | |
| Kurt Gustafson | M | 55 | 6 years | |
| Christopher McNulty | M | 47 | 5 years | |
| Caroline Levy | F | 61 | 1 years | |
| Patrick J. T. Vallance | M | 64 | - | |
| Mark J. Friedman | M | 66 | 3 years | |
| John David Coombe | M | 79 | 5 years | |
| H. Culp | M | 60 | 9 years | |
| Christopher Gent | M | 75 | 11 years | |
| Peter Traber | M | 69 | 3 years | |
| Robert Wilson | M | 81 | 11 years | |
| Tsz Ho Lau | M | 34 | 4 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| Maxine Gowen | M | 66 | 13 years | |
| Lisa Harrington | F | 57 | 1 years | |
| Richard Sykes | M | 79 | 7 years | |
| Michael Allen Luther | M | 67 | 15 years | |
| Jing Ji | M | 54 | 4 years | |
| David Wheadon | M | 66 | 5 years | |
| James Wu | M | - | 10 years | |
| John Clarke | M | - | - | |
| Monica Viziano | M | 57 | 6 years | |
| Chao Hong Hu | M | 58 | 1 years | |
| Myra Rosario Herrle | M | - | 9 years | |
| Vincent O'Neill | M | 55 | 3 years | |
| Joe McCann | M | 47 | 4 years | |
| Jordan A. Gropack | M | - | 1 years | |
| Lisa Bratkovich | F | - | 2 years | |
| Amy Boileau | M | - | 3 years | |
| Matthew Roberts | M | - | 2 years | |
| Brian Blakey | M | 61 | 6 years | |
| Vivid Sehgal | M | 56 | 6 years | |
| Stewart Mccallum | M | 58 | 9 years | |
| Will Black | M | 65 | 3 years | |
| Marc Rubin | M | 69 | 13 years | |
| Gill Dines | F | - | - | |
| Christopher Hogg | M | - | - | |
| Randall K. Johnson | M | 77 | 20 years | |
| Joseph M. Spagnardi | M | 60 | 11 years | |
| Peter Goodfellow | M | 72 | 8 years | |
| M. Berrey | M | 57 | 3 years | |
| William D. Smithburg | M | 86 | - | |
| Paul A. Allaire | M | - | - | |
| Donald F. McHenry | M | 87 | - | |
| John Hector McArthur | M | 90 | - | |
| Michael Steinmetz | M | 75 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | - |
| Howard H. Pien | M | 66 | 12 years | |
| F. Roger Hurn | M | 86 | - | |
| Lucy Shapiro | M | 83 | 5 years | |
| Denis Brodsky | M | 53 | 5 years | |
| Lisa Porter | M | 60 | 5 years | |
| Gary W. Christianson | M | 69 | 2 years | |
| Jennie Younger | F | - | 5 years | |
| John B. Ziegler | M | 78 | - | |
| Margaret Dalesandro | M | 77 | 2 years | |
| Paul Carter | M | 63 | 10 years | |
| Lauren Flanagan | F | - | - | |
| Tomer Kariv | M | 62 | 1 years | |
| Ran Nussbaum | M | 51 | 1 years | |
| Mark Berger | M | 69 | 5 years | |
| Robert J. DiVasto | M | 68 | 2 years | |
| Robert Copeland | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 52 | 52.00% |
| United States | 48 | 48.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeff Baxter
- Personal Network
